These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 36253903)
21. The effect of oral capsule of curcumin and vitamin E on the hot flashes and anxiety in postmenopausal women: A triple blind randomised controlled trial. Ataei-Almanghadim K; Farshbaf-Khalili A; Ostadrahimi AR; Shaseb E; Mirghafourvand M Complement Ther Med; 2020 Jan; 48():102267. PubMed ID: 31987231 [TBL] [Abstract][Full Text] [Related]
22. Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: a randomized controlled trial. LaCroix AZ; Freeman EW; Larson J; Carpenter JS; Joffe H; Reed SD; Newton KM; Seguin RA; Sternfeld B; Cohen L; Ensrud KE Maturitas; 2012 Dec; 73(4):361-8. PubMed ID: 23031421 [TBL] [Abstract][Full Text] [Related]
23. Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis. Bolaños R; Del Castillo A; Francia J Menopause; 2010; 17(3):660-6. PubMed ID: 20464785 [TBL] [Abstract][Full Text] [Related]
24. Effects of an equol-containing supplement on advanced glycation end products, visceral fat and climacteric symptoms in postmenopausal women: A randomized controlled trial. Yoshikata R; Myint KZY; Ohta H; Ishigaki Y PLoS One; 2021; 16(9):e0257332. PubMed ID: 34506596 [TBL] [Abstract][Full Text] [Related]
25. Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial. Elkins GR; Fisher WI; Johnson AK; Carpenter JS; Keith TZ Menopause; 2013 Mar; 20(3):291-8. PubMed ID: 23435026 [TBL] [Abstract][Full Text] [Related]
26. Equol improves menopausal symptoms in Japanese women. Aso T J Nutr; 2010 Jul; 140(7):1386S-9S. PubMed ID: 20484552 [TBL] [Abstract][Full Text] [Related]
27. Effect of omega-3 supplements on vasomotor symptoms in menopausal women: A systematic review and meta-analysis. Mohammady M; Janani L; Jahanfar S; Mousavi MS Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():295-302. PubMed ID: 30056356 [TBL] [Abstract][Full Text] [Related]
28. Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies. Zhu D; Chung HF; Dobson AJ; Pandeya N; Anderson DJ; Kuh D; Hardy R; Brunner EJ; Avis NE; Gold EB; El Khoudary SR; Crawford SL; Mishra GD Am J Obstet Gynecol; 2020 Dec; 223(6):898.e1-898.e16. PubMed ID: 32585222 [TBL] [Abstract][Full Text] [Related]
29. Direct and indirect effects of conjugated estrogens/bazedoxifene treatment on quality of life in postmenopausal women. Abraham L; Bushmakin AG; Dragon E; Komm BS; Pinkerton JV Maturitas; 2016 Dec; 94():173-179. PubMed ID: 27823739 [TBL] [Abstract][Full Text] [Related]
30. The Acupuncture on Hot Flashes Among Menopausal Women study: observational follow-up results at 6 and 12 months. Borud EK; Alraek T; White A; Grimsgaard S Menopause; 2010 Mar; 17(2):262-8. PubMed ID: 20009958 [TBL] [Abstract][Full Text] [Related]
31. Comparing the effects of face-to-face versus phone counseling based on cognitive-behavioral therapy for vasomotor symptoms in postmenopausal women: a randomized controlled trial. Sadeghijoola N; Afshari P; Jofreh MG; Haghighizadeh MH; Abedi P Postep Psychiatr Neurol; 2022 Sep; 31(3):114-120. PubMed ID: 37082224 [TBL] [Abstract][Full Text] [Related]
32. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial. Pinkerton JV; Constantine G; Hwang E; Cheng RF; Menopause; 2013 Jan; 20(1):28-37. PubMed ID: 23010882 [TBL] [Abstract][Full Text] [Related]
33. Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Vasomotor Symptoms in the Selective Estrogens, Menopause, and Response to Therapy Trials. Archer DF; Freeman EW; Komm BS; Ryan KA; Yu CR; Mirkin S; Pinkerton JV J Womens Health (Larchmt); 2016 Nov; 25(11):1102-1111. PubMed ID: 27676118 [TBL] [Abstract][Full Text] [Related]
34. A randomized, double-blind, multiple-dose escalation study of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) for moderate to severe menopausal symptoms and quality of life in postmenopausal women. Wang CC; Cheng KF; Lo WM; Law C; Li L; Leung PC; Chung TK; Haines CJ Menopause; 2013 Feb; 20(2):223-31. PubMed ID: 22990757 [TBL] [Abstract][Full Text] [Related]
35. Results of a pilot study of a cooling mattress pad to reduce vasomotor symptoms and improve sleep. Avis NE; Levine BJ; Coeytaux R Menopause; 2022 Aug; 29(8):973-978. PubMed ID: 35881974 [TBL] [Abstract][Full Text] [Related]
36. Relationship between changes in vasomotor symptoms and changes in menopause-specific quality of life and sleep parameters. Pinkerton JV; Abraham L; Bushmakin AG; Cappelleri JC; Komm BS Menopause; 2016 Oct; 23(10):1060-6. PubMed ID: 27404028 [TBL] [Abstract][Full Text] [Related]
37. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. Van Patten CL; Olivotto IA; Chambers GK; Gelmon KA; Hislop TG; Templeton E; Wattie A; Prior JC J Clin Oncol; 2002 Mar; 20(6):1449-55. PubMed ID: 11896091 [TBL] [Abstract][Full Text] [Related]
38. Effect of sulpiride on menopausal hot flashes: a randomized, double-blind, placebo-controlled clinical trial. Borba CM; Ferreira CF; Ferreira FV; Pérez-López FR; Wender MCO Gynecol Endocrinol; 2020 Mar; 36(3):247-251. PubMed ID: 31476924 [TBL] [Abstract][Full Text] [Related]
39. Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study. Burke GL; Legault C; Anthony M; Bland DR; Morgan TM; Naughton MJ; Leggett K; Washburn SA; Vitolins MZ Menopause; 2003; 10(2):147-53. PubMed ID: 12627040 [TBL] [Abstract][Full Text] [Related]
40. Body mass index and menopausal disorders during menopause affect vasomotor symptoms of postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes. Tane K; Egawa C; Takao S; Yamagami K; Miyashita M; Baba M; Ichii S; Konishi M; Kikawa Y; Minohata J; Okuno T; Miyauchi K; Wakita K; Suwa H; Hashimoto T; Nishino M; Matsumoto T; Hidaka T; Konishi Y; Sakoda Y; Miya A; Kishimoto M; Nishikawa H; Kono S; Kokufu I; Sakita I; Kitatsuji K; Oh K; Akazawa K; Miyoshi Y Breast Cancer; 2017 Jul; 24(4):528-534. PubMed ID: 27730528 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]